LCJ Amicus Curiae Brief in Support of Reversal in In Re Zantac (Ranitidine) litigation, Delaware Supreme Court

Click here to read amicus.

Previous
Previous

New Jersey Defense Association Proposed Amendment to NJRE 702

Next
Next

More Than 100 Companies Urge Adoption of Federal TPLF Disclosure Rules